A UK healthtech startup has secured $19 million to scale its rapid AI lung testing platform. The company's diagnostic software cuts test times for chronic respiratory disease from one hour down to just five minutes. This funding enables the team to expand clinical deployments and accelerate regulatory approvals for their machine learning diagnostics.
Opening Kapyn…